Effect of AQW051 on Cognitive Function in Patients With Chronic Stable Schizophrenia

Clinical trial NCT01163227 · COMPLETED

Trial details

NCT number: NCT01163227
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Disorders

Start date: 2010-05-01
Primary completion: 2011-09-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.